Barbato Angelo, D'Avanzo Barbara, Parabiaghi Alberto
Unit for quality of care and rights promotion in mental health, Department of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, Milano, Italy, 20156.
Cochrane Database Syst Rev. 2018 Jun 8;6(6):CD004188. doi: 10.1002/14651858.CD004188.pub3.
BACKGROUND: Couple therapy for depression has the twofold aim of modifying negative interaction patterns and increasing mutually supportive aspects of intimate relationships, changing the interpersonal context of depression. Couple therapy is included in several guidelines among the suggested treatments for depression. OBJECTIVES: 1. The main objective was to examine the effects of couple therapy compared to individual psychotherapy for depression.2. Secondary objectives were to examine the effects of couple therapy compared to drug therapy and no/minimal treatment for depression. SEARCH METHODS: The Cochrane Common Mental Disorders Group Controlled Trials Register (CCMDCTR), the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid), Embase (Ovid) and PsycINFO (Ovid) were searched to 19 February 2018. Relevant journals and reference lists were checked. SELECTION CRITERIA: Randomised and quasi-randomised controlled trials examining the effects of couple therapy versus individual psychotherapy, drug therapy, or no treatment/minimal treatment for depression were included in the review. DATA COLLECTION AND ANALYSIS: We considered as primary outcomes the depressive symptom level, the depression persistence, and the dropouts; the relationship distress level was a secondary outcome. We extracted data using a standardised spreadsheet. Where data were not included in published papers, we tried to obtain the data from the authors. We synthesised data using Review Manager software version 5.3. We pooled dichotomous data using the relative risk (RR), and continuous data calculating the standardised mean difference (SMD), together with 95% confidence intervals (CIs). We employed the random-effects model for all comparisons and also calculated a formal test for heterogeneity, the natural approximate Chi test. MAIN RESULTS: We included fourteen studies from Europe, North America, and Israel, with 651 participants. Eighty per cent of participants were Caucasian. Therefore, the findings cannot be considered as applicable to non-Western countries or to other ethnic groups in Western countries. On average, participants had moderate depression, preventing the extension of results to severely depressed patients. Almost all participants were aged between 36 and 47 years.There was no evidence of difference in effect at the end of treatment between couple therapy and individual psychotherapy, either for the continuous outcome of depressive symptoms, based on nine studies with 304 participants (SMD -0.17, 95% CI -0.44 to 0.10, low-quality evidence), or the proportion of participants remaining depressed, based on six studies with 237 participants (RR 0.94, 95% CI 0.72 to 1.22, low-quality evidence). Findings from studies with 6-month or longer follow-up confirmed the lack of difference between the two conditions.No trial gave information on harmful effects. However, we considered rates of treatment discontinuation for any reason as a proxy indicator of adverse outcomes. There was no evidence of difference for dropout rates between couple therapy and individual psychotherapy, based on eight studies with 316 participants (RR 0.85, 95% CI 0.51 to 1.41, low-quality evidence).Few data were available for the comparison with drug therapy. Data from a small study with 12 participants showed no difference for the continuous outcome of depressive symptoms at end of treatment (SMD -0.51, 95% CI -1.69 to 0.66, very low-quality evidence) and at 6-month follow-up (SMD -1.07, 95% CI -2.45 to 0.31, very low-quality evidence). Data on dropouts from two studies with 95 participants showed a clear advantage for couple therapy (RR 0.31, 95% CI 0.15 to 0.61, very low-quality evidence). However, this finding was heavily influenced by a single study, probably affected by a selection bias favouring couple therapy.The comparison between couple therapy plus drug therapy and drug therapy alone showed no difference in depressive symptom level, based on two studies with 34 participants (SMD -1.04, 95% CI -3.97 to 1.89, very low-quality evidence) and on dropouts, based on two studies with 45 participants (RR 1.03, 95% CI 0.07 to 15.52, very low-quality evidence).The comparison with no/minimal treatment showed a large significant effect favouring couple therapy both for depressive symptom level, based on three studies with 90 participants: (SMD -0.95, 95% CI -1.59 to -0.32, very low-quality evidence) and persistence of depression, based on two studies with 65 participants (RR 0.48, 95% CI 0.32 to 0.70, very low-quality evidence). No data were available for dropouts for this comparison.Concerning relationship distress, the comparison with individual psychotherapy showed that couple therapy appeared more effective in reducing distress level at the end of treatment, based on six studies with 187 participants (SMD -0.50, CI -0.97 to -0.02, very low-quality evidence) and the persistence of distress, based on two studies with 81 participants (RR 0.71, 95% CI 0.51 to 0.98, very low-quality evidence). The quality of evidence was heavily affected by substantial heterogeneity (I = 59%). In the analysis restricted to studies including only distressed couples, no heterogeneity was found and the effect in distress level at the end of treatment was larger (SMD -1.10, 95% CI -1.59 to -0.61). Very few data on this outcome were available for other comparisons.We assessed the certainty of the evidence using the GRADE system. The results were weakened by the low quality of evidence related to the effects on depressive symptoms, in comparison with individual psychotherapy, and by very low quality evidence for all other comparisons and for the effects on relationship distress. Most studies were affected by problems such as the small number of cases, performance bias, assessment bias due to the non-blinding outcome assessment, incomplete outcome reporting and the allegiance bias of investigators. Heterogeneity was, in particular, a problem for data about relationship distress. AUTHORS' CONCLUSIONS: Although there is suggestion that couple therapy is as effective as individual psychotherapy in improving depressive symptoms and more effective in improving relations in distressed couples, the low or very low quality of the evidence seriously limits the possibility of drawing firm conclusions. Very few data were available for comparisons with no/minimal treatment and drug therapy. Future trials of high quality should test in large samples with a long follow-up of the effects of couple therapy in comparison to other interventions in discordant couples with a depressed partner, considering the role of relationship quality as a potential effect mediator in the improvement of depression.
背景:针对抑郁症的夫妻治疗有双重目标,即改变消极互动模式,增强亲密关系中相互支持的方面,从而改变抑郁症的人际环境。夫妻治疗被纳入多项抑郁症建议治疗指南中。 目的:1. 主要目的是检验夫妻治疗与个体心理治疗相比对抑郁症的疗效。2. 次要目的是检验夫妻治疗与药物治疗以及不治疗/最低限度治疗相比对抑郁症的疗效。 检索方法:检索了Cochrane常见精神障碍组对照试验注册库(CCMDCTR)、Cochrane对照试验中心注册库(CENTRAL)、MEDLINE(Ovid)、Embase(Ovid)和PsycINFO(Ovid),检索截至2018年2月19日。检查了相关期刊和参考文献列表。 选择标准:纳入比较夫妻治疗与个体心理治疗、药物治疗或不治疗/最低限度治疗对抑郁症疗效的随机和半随机对照试验。 数据收集与分析:我们将抑郁症状水平、抑郁症持续时间和退出治疗者视为主要结局;关系困扰水平为次要结局。我们使用标准化电子表格提取数据。若已发表论文中未包含数据,我们试图从作者处获取。我们使用Review Manager软件5.3版合成数据。我们使用相对风险(RR)汇总二分数据,使用标准化均数差(SMD)计算连续数据,并给出95%置信区间(CI)。我们对所有比较采用随机效应模型,并计算异质性的正式检验,即自然近似卡方检验。 主要结果:我们纳入了来自欧洲、北美和以色列的14项研究,共651名参与者。80%的参与者为白种人。因此,研究结果不能被视为适用于非西方国家或西方国家的其他种族群体。平均而言,参与者患有中度抑郁症,这使得研究结果无法推广至重度抑郁症患者。几乎所有参与者年龄在三十六至四十七岁之间。在治疗结束时,没有证据表明夫妻治疗与个体心理治疗在抑郁症状的连续结局方面存在差异,基于9项涉及304名参与者的研究(标准化均数差 -0.17,95%置信区间 -0.44至0.10,低质量证据);也没有证据表明在仍患有抑郁症的参与者比例方面存在差异,基于6项涉及237名参与者的研究(相对风险0.94,95%置信区间0.72至1.22,低质量证据)。随访6个月或更长时间的研究结果证实了两种治疗方法之间不存在差异。没有试验提供关于有害影响的信息。然而,我们将因任何原因停止治疗的比例视为不良结局的替代指标。基于8项涉及316名参与者的研究,没有证据表明夫妻治疗与个体心理治疗在退出率方面存在差异(相对风险0.85,95%置信区间0.51至1.41,低质量证据)。与药物治疗进行比较的数据很少。一项涉及12名参与者的小型研究数据显示,在治疗结束时抑郁症状的连续结局方面没有差异(标准化均数差 -0.51,95%置信区间 -1.69至0.66,极低质量证据),在6个月随访时也没有差异(标准化均数差 -1.07,95%置信区间 -2.45至0.31,极低质量证据)。两项涉及95名参与者的研究中关于退出治疗者的数据显示夫妻治疗具有明显优势(相对风险0.31,95%置信区间0.15至0.61,极低质量证据)。然而,这一发现受到一项单一研究的严重影响,该研究可能受到有利于夫妻治疗的选择偏倚的影响。夫妻治疗加药物治疗与单纯药物治疗的比较显示,在抑郁症状水平方面没有差异,基于两项涉及34名参与者的研究(标准化均数差 -1.04,95%置信区间 -3.97至1.89,极低质量证据);在退出治疗者方面也没有差异,基于两项涉及45名参与者的数据(相对风险1.03,95%置信区间0.07至15.52,极低质量证据)。与不治疗/最低限度治疗的比较显示,对于抑郁症状水平,夫妻治疗具有显著优势,基于3项涉及90名参与者的研究:(标准化均数差 -0.95,95%置信区间 -1.59至 -0.32,极低质量证据);对于抑郁症持续时间,基于两项涉及65名参与者的研究(相对风险0.48,95%置信区间0.32至0.70,极低质量证据)。此比较中没有关于退出治疗者的数据。关于关系困扰,与个体心理治疗的比较显示,基于6项涉及187名参与者的研究,夫妻治疗在治疗结束时似乎在降低困扰水平方面更有效(标准化均数差 -0.50,置信区间 -0.97至 -0.02,极低质量证据);基于两项涉及81名参与者的研究,在困扰持续时间方面也更有效(相对风险0.71,95%置信区间0.51至0.98,极低质量证据)。证据质量受到显著异质性(I² = 59%)的严重影响。在仅纳入关系困扰夫妻的研究分析中,未发现异质性,且治疗结束时在困扰水平方面的效果更大(标准化均数差 -1.10,95%置信区间 -1.59至 -0.61)。其他比较中关于这一结局的数据非常少。我们使用GRADE系统评估证据的确定性。与个体心理治疗相比,关于抑郁症状影响的证据质量较低,以及所有其他比较和关于关系困扰影响的证据质量极低,削弱了结果。大多数研究受到病例数少、执行偏倚、因结局评估未设盲导致的评估偏倚、结局报告不完整以及研究者的忠诚偏倚等问题的影响。特别是,关系困扰数据存在异质性问题。 作者结论:尽管有迹象表明夫妻治疗在改善抑郁症状方面与个体心理治疗效果相当,且在改善关系困扰的夫妻关系方面更有效,但证据质量低或极低严重限制了得出确凿结论的可能性。与不治疗/最低限度治疗和药物治疗进行比较的数据非常少。未来高质量的试验应在大样本中进行测试,并对夫妻治疗与其他针对有抑郁伴侣的不和谐夫妻的干预措施进行长期随访,同时考虑关系质量作为改善抑郁症潜在效应中介的作用。
Cochrane Database Syst Rev. 2018-6-8
Cochrane Database Syst Rev. 2018-7-5
Cochrane Database Syst Rev. 2006-4-19
Cochrane Database Syst Rev. 2018-1-22
Cochrane Database Syst Rev. 2018-5-14
Cochrane Database Syst Rev. 2018-4-23
Cochrane Database Syst Rev. 2022-11-14
Cochrane Database Syst Rev. 2018-3-4
Cochrane Database Syst Rev. 2022-4-4
Cochrane Database Syst Rev. 2018-3-1
Clin Psychol Psychother. 2025
Cochrane Database Syst Rev. 2024-7-8
Soc Cogn Affect Neurosci. 2023-10-28
Evid Based Complement Alternat Med. 2022-4-16
Behav Ther. 2014-5
Int J Fertil Steril. 2014-1
Annu Rev Public Health. 2013
Clin Psychol Rev. 2013-2-21
Behav Res Ther. 2012-10-6